Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
ADMA Biologics Investors may have been Misled about Alleged Channel Stuffing – Contact BFA Law about the Pending Securities Fraud Class Action
-
ADMA Biologics (ADMA) Faces Securities Fraud Class Action after Channel Stuffing Allegations Cause 29% Stock Drop – Investors Notified to Contact BFA Law
-
ADMA Biologics Accused of Securities Fraud over Channel Stuffing Allegations in Filed Class Action Lawsuit – Investors Notified to Contact BFA Law
-
"Visting our CDMO partner provides tremendous benefits being able to visualize future cGMP production of PRP"
-
ADMA Biologics Investors with Losses may have been Misled by the Company and are Urged to Contact BFA Law about the Ongoing Securities Class Action
-
ADMA Biologics (ADMA) Investigated for Alleged Channel Stuffing – Contact BFA Law if You Suffered Losses
-
Intravacc Highlights Integrated Analytical Capabilities to Accelerate Vaccine and Biologics Development
-
Intravacc Highlights Integrated Analytical Capabilities to Accelerate Vaccine and Biologics Development
-
Intravacc Highlights Integrated Analytical Capabilities to Accelerate Vaccine and Biologics Development
-
Intravacc Highlights Integrated Analytical Capabilities to Accelerate Vaccine and Biologics Development